Sulfonylurea [EPC]

Known as: Sulfonylurea, Sulfonylurea-class Agent 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1962-2018
051019622018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The sulfonylurea receptor 1 (Sur1)-NC(Ca-ATP) channel plays a central role in necrotic cell death in central nervous system (CNS… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
CONTEXT After failure of metformin monotherapy, many second-line, glucose-lowering therapies are available to treat people with… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
ATP-sensitive K+ (KATP) channel openers are vasodilators that activate both plasma membrane and mitochondrial KATP channels. Here… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Background A 12-week-old female presented with neonatal diabetes. Insulin therapy alleviated the diabetes, but the patient showed… (More)
  • figure 1
  • figure 2
Is this relevant?
2007
2007
We previously found that chronic exposure to glibenclamide inhibits acute glibenclamide-induced insulin secretion by reducing the… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Heterozygous activating mutations in KCNJ11, encoding the Kir6.2 subunit of the ATP-sensitive potassium (K(ATP… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Loss of beta-cell mass and function raises a concern regarding the application of sulfonylureas for the treatment of type 2… (More)
Is this relevant?
2004
2004
Loss of -cell mass and function raises a concern regarding the application of sulfonylureas for the treatment of type 2 diabetes… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
BACKGROUND AND PURPOSE Sulfonylurea drugs inhibit ATP-dependent potassium channels and may increase mortality after myocardial… (More)
  • table 1
  • table 3
  • table 2
Is this relevant?
1993
1993
Sulfonylurea drugs are widely used in the therapy of NIDDM. The improvement of glucose tolerance after long-term treatment of… (More)
Is this relevant?